文献速递先天性心脏病外科

三尖瓣闭锁患者腔肺分流术后死亡或移植与Fontan完成的相关因素

Factors associated with mortality or transplantation versus Fontan completion after cavopulmonary shunt for patients with tricuspid atresia.
PubMed 文献 · J Thorac Cardiovasc Surg · 2021-04-30

基于先天性心脏外科医师学会三尖瓣闭锁队列的417例婴儿(1999年1月至2020年2月,40家机构),采用参数竞争风险方法分析腔肺分流(CPS)后死亡/移植与过渡至Fontan的相关因素。382例接受CPS,5年内5%死亡或移植而未过渡至Fontan,91%过渡至Fontan。术前中度及以上二尖瓣反流、CPS时肺动脉环缩(PAB)、术后上腔静脉干预及CPS拆解与死亡/移植相关。

要点

  • 三尖瓣闭锁CPS后5年内91%过渡至Fontan,5%死亡或移植。
  • 术前中度及以上二尖瓣反流是死亡/移植的高危因素(HR 3.0)。
  • CPS时行肺动脉环缩与死亡风险增加及Fontan完成减少相关。

核心结论

  • 三尖瓣闭锁患者CPS后死亡率值得关注,术前二尖瓣反流者仍为高危群体。
  • CPS时行肺动脉环缩与死亡风险增加及Fontan完成减少相关,可能反映前向肺血流在CPS循环中的不利效应。

研究设计与样本

  • 多中心队列研究,纳入40家机构1999年1月至2020年2月收治的417例小于3月龄三尖瓣闭锁婴儿。
  • 采用参数竞争风险方法分析CPS后死亡/移植(未完成Fontan)与过渡至Fontan的竞争终点。

主要发现

  • 382例接受CPS,CPS后5年内5%死亡或移植而未过渡至Fontan,91%过渡至Fontan。
  • 产前诊断(HR 0.74,P < .001)和CPS时肺动脉环缩(HR 0.50,P < .001)与Fontan完成负相关。
  • 术前中度及以上二尖瓣反流(HR 3.0,P < .001)、同期二尖瓣修复(HR 11.0,P < .001)、CPS时肺动脉环缩(HR 3.0,P < .001)、术后上腔静脉干预(HR 9.0,P < .001)及CPS拆解(HR 40.0,P < .001)与死亡/移植相关。

临床怎么用

  • 对三尖瓣闭锁拟行CPS患者,应评估术前二尖瓣反流程度并识别高危人群。
  • CPS时行肺动脉环缩需权衡死亡风险增加及Fontan完成减少的可能不利影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Tricuspid atresia with normally related great vessels (TA) is considered the optimal substrate for the Fontan pathway. The factors associated with death or transplantation after cavopulmonary shunt (CPS) are underappreciated. We aimed to determine factors associated with CPS-Fontan interstage death/transplantation versus transition to Fontan in TA. METHODS: A total of 417 infants younger than 3 months of age with TA were enrolled (January 1999 to February 2020) from 40 institutions into the Congenital Heart Surgeons' Society TA cohort. Parametric competing risk methodology was used to determine factors associated with the competing end points of death/transplantation without Fontan completion, and transition to Fontan. RESULTS: CPS was performed in 382 patients with TA; of those, 5% died or underwent transplantation without transition to Fontan and 91% transitioned to Fontan by 5 years after CPS. Prenatal diagnosis (hazard ratio [HR], 0.74; P < .001) and pulmonary artery band (PAB) at CPS (HR, 0.50; P < .001) were negatively associated with Fontan completion. Preoperative moderate or greater mitral valve regurgitation (HR, 3.0; P < .001), concomitant mitral valve repair (HR, 11.0; P < .001), PAB at CPS (HR, 3.0; P < .001), postoperative superior vena cava interventions (HR, 9.0; P < .001), and CPS takedown (HR, 40.0; P < .001) were associated with death/transplantation. CONCLUSIONS: The mortality rate after CPS in patients with TA is notable. Those with preoperative mitral valve regurgitation remain a high-risk group. PAB at the time of CPS being associated with both increased risk of death and decreased Fontan completion may represent a deleterious effect of antegrade pulmonary blood flow in the CPS circulation.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Callahan CP, Jegatheeswaran A, Barron DJ, et al. Factors associated with mortality or transplantation versus Fontan completion after cavopulmonary shunt for patients with tricuspid atresia. J Thorac Cardiovasc Surg. 2021. PMID: 34045062. doi:10.1016/j.jtcvs.2021.04.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。